It is well-known that defi ciency or over exposure to various elements has noticeable eff ects on human health. Th e eff ect of an element is determined by several characteristics, including absorption, metabolism, and degree of interaction with physiological processes. Iron is an essential element for almost all living organisms as it participates in a wide variety of metabolic processes, including oxygen transport, deoxyribonucleic acid (DNA) synthesis, and electron transport. However, as iron can form free radicals, its concentration in body tissues must be tightly regulated because in excessive amounts, it can lead to tissue damage. Disorders of iron metabolism are among the most common diseases of humans and encompass a broad spectrum of diseases with diverse clinical manifestations, ranging from anemia to iron overload, and possibly to neurodegenerative diseases. In this review, we discuss the latest progress in studies of iron metabolism and bioavailability, and our current understanding of human iron requirement and consequences and causes of iron defi ciency. Finally, we discuss strategies for prevention of iron defi ciency.
are highly insoluble, and thus is not readily available for uptake by organisms. [2] In response, various cellular mechanisms have evolved to capture iron from the environment in biologically useful forms. Examples are siderophores secreted by microbes to capture iron in a highly specifi c complex [12] or mechanisms to reduce iron from the insoluble ferric iron (Fe +3 ) to the soluble ferrous form (Fe +2 ) as in yeasts. [13] Many of the mechanisms found in lower organisms, have analogous counterparts in higher organisms, including humans. In the human body, iron mainly exists in complex forms bound to protein (hemoprotein) as heme compounds (hemoglobin or myoglobin), heme enzymes, or nonheme compounds (flavin-iron enzymes, transferring, and ferritin). [3] The body requires iron for the synthesis of its oxygen transport proteins, in particular hemoglobin and myoglobin, and for the formation of heme enzymes and other iron-containing enzymes involved in electron transfer and oxidation-reductions. [14, 3] Almost two-thirds of the body iron is found in the hemoglobin present in circulating erythrocytes, 25% is contained in a readily mobilizable iron store, and the remaining 15% is bound to myoglobin in muscle tissue and in a variety of enzymes involved in the oxidative metabolism and many other cell functions. [15] Iron is recycled and thus conserved by the body. Figure 1 shows a schematic diagram of iron cycle in the body.
INTRODUCTION
From ancient times, man has recognized the special role of iron in health and disease. [1] Iron had early medicinal uses by Egyptians, Hindus, Greeks, and Romans. [2, 3] During the 17 th century, iron was used to treat chlorosis (green disease), a condition o en resulting from the iron defi ciency. [4] However, it was not until 1932 that the importance of iron was fi nally se led by the convincing proof that inorganic iron was needed for hemoglobin synthesis. [5] For many years, nutritional interest in iron focused on its role in hemoglobin formation and oxygen transport. [6] Nowadays, although low iron intake and/ or bioavailability are responsible for most anemia in industrialized countries, they account for only about half of the anemia in developing countries, [7] where infectious and inflammatory diseases (especially malaria), blood loss from parasitic infections, and other nutrient defi ciencies (vitamin A, ribofl avin, folic acid, and vitamin B12) are also important causes. [8] Biochemistry and physiology In contrast to zinc, iron is an abundant element on earth [2, 9] and is a biologically essential component of every living organism. [10, 11] However, despite its geologic abundance, iron is o en a growth limiting factor in the environment. [9] This apparent paradox is due to the fact that in contact with oxygen iron forms oxides, which Iron is delivered to tissues by circulating transferrin, a transporter that captures iron released into the plasma mainly from intestinal enterocytes or reticuloendothelial macrophages. The binding of iron-laden transferrin to the cell-surface transferrin receptor (TfR) 1 results in endocytosis and uptake of the metal cargo. Internalized iron is transported to mitochondria for the synthesis of heme or iron-sulfur clusters, which are integral parts of several metalloproteins, and excess iron is stored and detoxifi ed in cytosolic ferritin.
METABOLISM

Absorption
The fraction of iron absorbed from the amount ingested is typically low, but may range from 5% to 35% depending on circumstances and type of iron. [3] Iron absorption occurs by the enterocytes by divalent metal transporter 1, a member of the solute carrier group of membrane transport proteins. This takes place predominantly in the duodenum and upper jejunum. [16] It is then transferred across the duodenal mucosa into the blood, where it is transported by transferrin to the cells or the bone marrow for erythropoiesis [producing red blood cells (RBCs)] . [14, 17, 18] A feedback mechanism exists that enhances iron absorption in people who are iron defi cient. In contrast, people with iron overload dampen iron absorption via hepcidin. It is now generally accepted that iron absorption is controlled by ferroportin which allows or does not allow iron from the mucosal cell into the plasma.
The physical state of iron entering the duodenum greatly infl uences its absorption. At physiological pH, ferrous iron (Fe +2 ) is rapidly oxidized to the insoluble ferric (Fe +3 ) form. Gastric acid lowers the pH in the proximal duodenum reducing Fe +3 in the intestinal lumen by ferric reductases, thus allowing the subsequent transport of Fe +2 across the apical membrane of enterocytes. This enhances the solubility and uptake of ferric iron. When gastric acid production is impaired (for instance by acid pump inhibitors such as the drug, prilosec), iron absorption is reduced substantially.
Dietary heme can also be transported across the apical membrane by a yet unknown mechanism and subsequently metabolized in the enterocytes by heme oxygenase 1 (HO-1) to liberate (Fe   +2   ) . [19] This process is more effi cient than the absorption of inorganic iron and is independent of duodenal pH. It is thus not infl uenced by inhibitors such as phytate and polyphenols. Consequently, red meats high in hemoglobin are excellent nutrient sources of iron. Directly internalized Fe +2 is processed by the enterocytes and eventually (or not) exported across the basolateral membrane into the bloodstream via Fe +2 transporter ferroportin. The ferroportinmediated effl ux of Fe +2 is coupled by its reoxidation to Fe +2 , catalyzed by the membrane-bound ferroxidase hephaestin that physically interacts with ferroportin [20] and possibly also by its plasma homologue ceruloplasmin. Exported iron is scavenged by transferrin, which maintains Fe +3 in a redoxinert state and delivers it into tissues. The total iron content of transferrin (≈3 mg) corresponds to less than 0.1% of body iron, but it is highly dynamic and undergoes more than 10 times daily turnover to sustain erythropoiesis. The transferrin iron pool is replenished mostly by iron recycled from eff ete RBCs and, to a lesser extent, by newly absorbed dietary iron. Senescent RBCs are cleared by reticuloendothelial macrophages, which metabolize hemoglobin and heme, and release iron into the bloodstream. By analogy to intestinal enterocytes, macrophages export Fe +2 from their plasma membrane via ferroportin, in a process coupled by reoxidation of Fe +2 to Fe +3 by ceruloplasmin and followed by the loading of Fe +3 to transferrin. [21] Theil et al., [21] recently reported that an independent mechanism also exists for the absorption of plant ferritins mostly present in legumes. However, the relevance of the ferritin transporter is unclear as most ferritin seems to be degraded during food processing and digestion, thereby releasing inorganic iron from the ferritin shell for absorption by the normal mechanism. [22] As one ferritin molecule contains 1000 or more iron atoms, and should also be unaff ected by iron absorption inhibitors, such a mechanism would provide an important source of iron in the developing world where legumes are commonly consumed.
Regulation of iron homeostasis
Since iron is required for a number of diverse cellular functions, a constant balance between iron uptake, transport, storage, and utilization is required to maintain iron homeostasis. [11] As the body lacks a defi ned mechanism for the active excretion of iron, iron balance is mainly regulated at the point of absorption. [23, 24] Hepcidin is a circulating peptide hormone secreted by the liver that plays a central role in the regulation of iron homeostasis. It is the master regulator of systemic iron homeostasis, coordinating the use and storage of iron with iron acquisition. [25] This hormone is primarily produced by hepatocytes and is a negative regulator of iron entry into plasma [ Figure 2 ]. Hepcidin acts by binding to ferroportin, an iron transporter present on cells of the intestinal duodenum, macrophages, and cells of the placenta. Binding of hepcidin induces ferroportin internalization and degradation. [26] The loss of ferroportin from the cell surface prevents iron entry into plasma [ Figure 2a ]. Decreased iron entry into plasma results in low transferrin saturation and less iron is delivered to the developing erythroblast. Conversely, decreased expression of hepcidin leads to increased cell surface ferroportin and increased iron absorption [27] [ Figure 2c ]. In all species, the concentration of iron in biological fl uids is tightly regulated to provide iron as needed and to avoid toxicity, because iron excess can lead to the generation of reactive oxygen species. [28] Iron homeostasis in mammals is regulated at the level of intestinal absorption, as there is no excretory pathway for iron.
Plasma hepcidin levels are regulated by diff erent stimuli, including cytokines, plasma iron, anemia, and hypoxia. Dysregulation of hepcidin expression results in iron disorders. Overexpression of hepcidin leads to the anemia of chronic disease, while low hepcidin production results in hereditary hemochromatosis (HFE) with consequent iron accumulation in vital organs [ Figure 2 ]. Most hereditary iron disorders result from inadequate hepcidin production relative to the degree of tissue iron accumulation. Impaired hepcidin expression has been shown to result from mutations in any of 4 diff erent genes: TfR2, HFE, hemochromatosis type 2 (HFE2), and hepcidin antimicrobial peptide (HAMP). Mutations in HAMP, the gene that encodes hepcidin, result in iron overload disease, as the absence of hepcidin permits constitutively high iron absorption. The role for other genes (TFR2, HFE, and HFE2) in the regulation of hepcidin production has been unclear. [27] Storage Ferritin concentration together with that of hemosiderin refl ects the body iron stores. They store iron in an insoluble form and are present primarily in the liver, spleen, and bone marrow. [2] The majority of iron is bound to the ubiquitous and highly conserved iron-binding protein, ferritin. [18] Hemosiderin is an iron storage complex that less readily releases iron for body needs. Under steady state conditions, serum ferritin concentrations correlate well with total body iron stores. [29] Thus, serum ferritin is the most convenient laboratory test to estimate iron stores.
Excretion
Apart from iron losses due to menstruation, other bleeding or pregnancy, iron is highly conserved and not readily lost from the body. [30] There are some obligatory loss of iron from the body that results from the physiologic exfoliation of cells from epithelial surfaces, [30] including the skin, genitourinary tract, and gastrointestinal tract. [3] However, these losses are estimated to be very limited (≈1 mg/day). [31] Iron losses through bleeding can be substantial and excessive menstrual blood loss is the most common cause of iron defi ciency in women.
BIOAVAILABILITY
Dietary iron occurs in two forms: heme and nonheme. [23] The primary sources of heme iron are hemoglobin and myoglobin from consumption of meat, poultry, and fi sh, whereas nonheme iron is obtained from cereals, pulses, legumes, fruits, and vegetables. [32] Heme iron is highly bioavailable (15%-35%) and dietary factors have little eff ect on its absorption, whereas nonheme iron absorption is much lower (2%-20%) and strongly infl uenced by the presence of other food components. [23] On the contrary, the quantity of nonheme iron in the diet is manyfold greater than that of heme-iron in most meals. Thus despite its lower bioavailability, nonheme iron generally contributes more to iron nutrition than heme-iron. [33] Major inhibitors of iron absorption are phytic acid, polyphenols, calcium, and peptides from partially digested proteins. [23] Enhancers are ascorbic acid and muscle tissue which may reduce ferric High levels of hepcidin in the bloodstream result in the internalization and degradation of the iron exporter ferroportin. Loss of cell surface ferroportin results in macrophage iron loading, low plasma iron levels, and decreased erythropoiesis due to decreased transferrin-bound iron. The decreased erythropoiesis gives rise to the anemia of chronic disease. (b) Normal hepcidin levels, in response to iron demand, regulate the level of iron import into plasma, normal transferrin saturation, and normal levels of erythropoiesis. (c) Hemochromatosis, or iron overload, results from insuffi cient hepcidin levels, causing increased iron import into plasma, high transferrin saturation, and excess iron deposition in the liver. Source: De Domenico, et al. [27] a b c iron to ferrous iron and bind it in soluble complexes which are available for absorption [23] Factors enhancing iron absorption A number of dietary factors influence iron absorption. Ascorbate and citrate increase iron uptake in part by acting as weak chelators to help to solubilize the metal in the duodenum [ Table 1 ]. [34] Iron is readily transferred from these compounds into the mucosal lining cells. The dose-dependent enhancing eff ect of native or added ascorbic acid on iron absorption has been shown by researchers. [34] The enhancing eff ect is largely due to its ability to reduce ferric to ferrous iron but is also due to its potential to chelate iron. [35] Ascorbic acid will overcome the negative eff ect on iron absorption of all inhibitors, which include phytate, [36] polyphenols, [37] and the calcium and proteins in milk products, [38] and will increase the absorption of both native and fortifi cation iron. In fruit and vegetables, the enhancing eff ect of ascorbic acid is o en cancelled out by the inhibiting eff ect of polyphenols. [39] Ascorbic acid is the only absorption enhancer in vegetarian diets, and iron absorption from vegetarian and vegan meals can be best optimized by the inclusion of ascorbic acidcontaining vegetables. [40] Cooking, industrial processing, and storage degrade ascorbic acid and remove its enhancing eff ect on iron absorption. [41] The enhancing effect of meat, fish, or poultry on iron absorption from vegetarian meals has been shown, [42] and 30 g muscle tissue is considered equivalent to 25 mg ascorbic acid. [33] Bjorn-Rasmussen and Hallberg [43] reported that the addition of chicken, beef, or fi sh to a maize meal increased nonheme iron absorption 2-3-fold with no infl uence of the same quantity of protein added as egg albumin. As with ascorbic acid, it has been somewhat more diffi cult to demonstrate the enhancing eff ect of meat in multiple meals and complete diet studies. Reddy et al., [44] reported only a marginal improvement in iron absorption (35%) in self-selected diets over 5 days when daily muscle tissue intake was increased to 300 g/day, although, in a similar 5-day study, 60 g pork meat added to a vegetarian diet increased iron absorption by 50%. [45] Factors inhibiting iron absorption In plant-based diets, phytate (myo-inositol hexakisphosphate) is the main inhibitor of iron absorption. [23] The negative eff ect of phytate on iron absorption has been shown to be dose dependent and starts at very low concentrations of 2-10 mg/meal. [37, 46] The molar ratio of phytate to iron can be used to estimate the eff ect on absorption. The ratio should be 1:1 or preferably, 0.4:1 to signifi cantly improve iron absorption in plain cereal or legume-based meals that do not contain any enhancers of iron absorption, or, 6:1 in composite meals with certain vegetables that contain ascorbic acid and meat as enhancers. [47] Polyphenols occur in various amounts in plant foods and beverages, such as vegetables, fruit, some cereals and legumes, tea, coff ee, and wine. The inhibiting eff ect of polyphenols on iron absorption has been shown with black tea and to a lesser extent with herbal teas. [48, 49] In cereals and legumes, polyphenols add to the inhibitory eff ect of phytate, as was shown in a study that compared high and low polyphenol sorghum. [23] Calcium has been shown to have negative effects on nonheme and heme iron absorption, which makes it diff erent from other inhibitors that aff ect nonheme iron absorption only. [50] Dose-dependent inhibitory eff ects were shown at doses of 75-300 mg when calcium was added to bread rolls and at doses of 165 mg calcium from milk products. [51] It is proposed that single-meal studies show negative eff ects of calcium on iron absorption, whereas multiple-meal studies, with a wide variety of foods and various concentrations of other inhibitors and enhancers, indicate that calcium has only a limited eff ect on iron absorption. [52] Animal proteins such as milk proteins, egg proteins, and albumin, have been shown to inhibit iron absorption. [53] The two major bovine milk protein fractions, casein and whey, and egg white were shown to inhibit iron absorption in humans. [54] Proteins from soybean also decrease iron absorption. [55] Competition with iron Competition studies suggest that several other heavy metals may share the iron intestinal absorption pathway. These include lead, manganese, cobalt, and zinc [ Table 1 ]. As iron defi ciency o en coexists with lead intoxication, this interaction can produce particularly serious medical complications in children. [56] Lead is a particularly pernicious element to iron metabolism. [57] Lead is taken up by the iron absorption machinery (DTM1), and secondarily blocks iron through competitive inhibition. Further, lead interferes with a number of important iron-dependent metabolic steps such as heme biosynthesis. This multifaceted infl uence has particularly dire consequences in children, were lead not only produces anemia, but can impair cognitive 
HUMAN REQUIREMENTS
During early infancy, iron requirements are met by the li le iron contained in the human milk. [58] The need for iron rises markedly 4-6 months a er birth and amounts to about 0.7-0.9 mg/day during the remaining part of the fi rst year.
[58] Between 1 and 6 years of age, the body iron content is again doubled. [58] Iron requirements are also very high in adolescents, particularly during the period of growth spurt. Girls usually have their growth spurt before menarche, but growth is not fi nished at that time. In boys there is a marked increase in hemoglobin mass and concentration during puberty. In this stage, iron requirements increase to a level above the average iron requirements in menstruating women [58] [see Table 2 ].
The average adult stores about 1-3 g of iron in his or her body. A fine balance between dietary uptake and loss maintains this balance. About 1 mg of iron is lost each day through sloughing of cells from skin and mucosal surfaces, including the lining of the gastrointestinal tract. [59] Menstruation increases the average daily iron loss to about 2 mg per day in premenopausal female adults. [60] The augmentation of body mass during neonatal and childhood growth spurts transiently boosts iron requirements. [61] A dietary intake of iron is needed to replace iron lost in the stools and urine as well as through the skin. These basal losses represent approximately 0.9 mg of iron for an adult male and 0.8 mg for an adult female. [62] The iron lost in menstrual blood must be taken into consideration for women of reproductive age [ Table 2 ].
GROUPS AT HIGH RISK
The highest probability of suffering iron deficiency is found in those parts of a population that have inadequate access to foods rich in absorbable iron during stages of high iron demand. These groups correspond to children, adolescents, and women of reproductive age, in particular during pregnancy. [63, 58] In the case of infants and adolescents, the increased iron demand is the result of rapid growth. For women of reproductive age the principle reason is the excessive blood loss during menstruation. During pregnancy, there is a signifi cant increase in iron requirement due to the rapid growth of the placenta and the fetus and the expansion of the globular mass. [63] In contrast, adult men and postmenopausal women are at low risk of iron defi ciency and the amount of iron in a normal diet is usually suffi cient to cover their physiological requirements. [63] 
CONSEQUENCES AND CAUSES OF IRON DEFICIENCY
Consequences of iron defi ciency
Iron defi ciency is defi ned as a condition in which there are no mobilizable iron stores and in which signs of a compromised supply of iron to tissues, including the erythron, are noted. [64] Iron defi ciency can exist with or without anemia. Some functional changes may occur in the absence of anemia, but the most functional defi cits appear to occur with the development of anemia. [2] Even mild and moderate forms of iron defi ciency anemia can be associated with functional impairments aff ecting cognitive development, [65] immunity mechanisms, [66] and work capacity. [67] Iron defi ciency during pregnancy is associated with a variety of adverse outcomes for both mother and infant, including increased risk of sepsis, maternal mortality, perinatal mortality, and low birth weight. [68] Iron defi ciency and anemia also reduce learning ability and are associated with increased rates of morbidity. [68] Causes of iron defi ciency Iron defi ciency results from depletion of iron stores and occurs when iron absorption cannot keep pace over an extended period with the metabolic demands for iron to sustain growth and to replenish iron loss, which is primarily related to blood loss. [2] The primary causes of iron defi ciency include low intake of bioavailable iron, increased iron requirements as a result of rapid growth, pregnancy, menstruation, and excess blood loss caused by pathologic infections, such as hook worm and whipworm causing gastrointestinal blood loss [69] [70] [71] [72] and impaired absorption of iron. [73] The frequency of iron defi ciency rises in female adolescents because menstrual iron losses are superimposed with needs for rapid growth. [74] Other risk factors for iron defi ciency in young women are high parity, use of an intrauterine device, and vegetarian diets. [75] Nutritional iron deficiency arises when physiological requirements cannot be met by iron absorption from the diet. [72] Dietary iron bioavailability is low in populations consuming monotonous plant-based diets with li le meat. [72] In many developing countries, plant-based weaning-foods are rarely fortifi ed with iron, and the frequency of anemia exceeds 50% in children younger than 4 years. [64] When iron stores are depleted and insufficient iron is available for erythropoiesis, hemoglobin synthesis in erythrocyte precursors become impaired and hematologic signs of iron defi ciency anemia appear.
EVALUATION OF IRON STATUS
Iron defi ciency and eventually anemia develop in stages and can be assessed by measuring various biochemical indices. Although some iron enzymes are sensitive to iron defi ciency, [63] their activity has not been used as a successful routine measure of iron status. [2] Laboratory measurements are essential for a proper diagnosis of iron defi ciency. They are most informative when multiple measures of iron status are examined and evaluated in the context of nutritional and medical history.
The plasma or serum pool of iron is the fraction of all iron in the body that circulates bound primarily to transferrin. Three ways of estimating the level of iron in the plasma or serum include 1) measuring the total iron content per unit volume in μg/dL; 2) measuring the total number of binding sites for iron atoms on transferrin, known as total ironbinding capacity in μg/dL 2 ; and 3) estimating the percentage of the two bindings sites on all transferrin molecules that are occupied called the percentage transferrin saturation. [76] However, marked biologic variation can occur in these values as a result of diurnal variation, the presence of infection or infl ammatory conditions and recent dietary iron intake. [76] Zinc protoporphyrin refl ects the shortage of iron supply in the last stages of hemoglobin synthesis so that zinc is inserted into the protoporphyrin molecule in the place of iron. Zinc protoporphyrin can be detected in RBCs by fl uorimetry and is a measure of the severity of iron defi ciency. [76] Serum ferritin is a good indicator of body iron stores under most circumstances. When the concentration of serum ferritin is ≥15 μg/L iron stores are present; higher concentrations refl ect the size of the iron store; when the concentration is low (<12 μg/L for <5 years of age and <15 μg/L for >5 years of age) iron stores are depleted. [76] However, ferritin is an acute phase reactant protein and its serum concentrations can be elevated, irrespective of a change in iron stores, by infection or infl ammation. [76, 2] This means that it might be diffi cult to interpret the concentration of ferritin where infectious diseases are common.
Another indicator of iron status is the concentration of TfR in serum. Since TfR is mostly derived from developing RBCs, it refl ects the intensity of erythropoiesis and the demand for iron. As iron stores are exhausted, the concentration rises in iron defi ciency anemia indicating sever iron insuffi ciency. This is provided that there are no other causes of abnormal erythropoiesis. [76] Clinical studies indicate that the serum TfR is less aff ected by infl ammation than serum ferritin. [77] The major advantage of TfR as an indicator is the possibility of estimating the magnitude of the functional iron defi cit once iron stores are depleted. [78] The ratio of TfR to ferritin (TfR/ferritin) was designed to evaluate changes in both stored iron and functional iron and was thought to be more useful than either TfR or ferritin alone. [79] TfR/ferritin has been used to estimate body iron stores in both children and adults. [80] However, the high cost and the lack of standardization of the TfR assay so far have limited the applicability of the method. [81] Low hemoglobin concentration is a measure of anemia, the end stage of iron defi ciency. [76, 2] 
ANEMIA AND ITS CAUSES
Anemia describes the condition in which the number of RBCs in the blood is low, or the blood cells have less than the normal amount of hemoglobin. A person who has anemia is called anemic. The purpose of the RBC is to deliver oxygen from the lungs to other parts of the body. The hemoglobin molecule is the functional unit of the RBCs and is a complex protein structure that is inside the RBCs. Even though the RBCs are made within the bone marrow, many other factors are involved in their production. For example, iron is a very important component of the hemoglobin molecule; erythropoietin, a molecule secreted by the kidneys, promotes the formation of RBCs in the bone marrow.
Having the correct number of RBCs and prevention of anemia requires cooperation among the kidneys, the bone marrow, and nutrients within the body. If the kidneys or bone marrow are not functioning, or the body is poorly nourished, then normal RBC count and functions may be diffi cult to maintain.
Anemia is actually a sign of a disease process rather than a disease itself. It is usually classifi ed as either chronic or acute. Chronic anemia occurs over a long period of time. Acute anemia occurs quickly. Determining whether anemia has been present for a long time or whether it is something new, assists doctors in fi nding the cause. This also helps predict how severe the symptoms of anemia may be. In chronic anemia, symptoms typically begin slowly and progress gradually; whereas in acute anemia symptoms can be abrupt and more distressing.
RBCs live about 100 days, so the body is constantly trying to replace them. In adults, RBC production occurs in the bone marrow. Doctors try to determine if a low RBC count is caused by increased blood loss of RBCs or from decreased production of them in the bone marrow. Knowing whether the number of white blood cells and/or platelets has changed also helps determine the cause of anemia.
World Health Organization (WHO) estimates that two billion people are anemic worldwide and attribute approximately 50% of all anemia to iron defi ciency. [64] It occurs at all stages of the life cycle but is more prevalent in pregnant women and young children. [82] Anemia is the result of a wide variety of causes that can be isolated, but more o en coexist. Some of these causes include the following:
Iron defi ciency anemia
The most signifi cant and common cause of anemia is iron defi ciency. [82] If iron intake is limited or inadequate due to poor dietary intake, anemia may occur as a result. This is called iron defi ciency anemia. Iron defi ciency anemia can also occur when there are stomach ulcers or other sources of slow, chronic bleeding (colon cancer, uterine cancer, intestinal polyps, hemorrhoids, etc). [83] Anemia of chronic disease Any long-term medical condition can lead to anemia. This type of anemia is the second most prevalent a er anemia caused by iron defi ciency and develops in patients with acute or chronic systemic illness or infl ammation. [84] The condition has thus been termed "anemia of infl ammation" due to elevated hepcidin which blocks both the recycling of iron from the macrophages and iron absorption. [85] Anemia from active bleeding Loss of blood through heavy menstrual bleeding or wounds can cause anemia. [82] Gastrointestinal ulcers or cancers such as cancer of the colon may slowly lose blood and can also cause anemia. [86, 87] Anemia related to kidney disease The kidneys releases a hormone called the erythropoietin that helps the bone marrow make RBCs. In people with chronic (long-standing) kidney disease, the production of this hormone is diminished, and this in turn diminishes the production of RBCs, causing anemia. [88] Although defi ciency of erythropoietin is the primary cause of anemia in chronic renal failure, it is not the only cause. Therefore, a minimal workup is necessary to rule out iron defi ciency and other cell-line abnormalities. [89] Anemia related to pregnancy A gain in plasma volume during pregnancy dilutes the RBCs and may be refl ected as anemia. [90] Iron defi ciency anemia accounts for 75% of all anemia in pregnancy. [90] Anemia related to poor nutrition Vitamins and minerals are required to make RBCs. In addition to iron, vitamin B12, viamin A, folate, ribofl avin, and copper are required for the proper production of hemoglobin. [82] Defi ciency in any of these micronutrients may cause anemia because of inadequate production of RBCs. Poor dietary intake is an important cause of low vitamin levels and therefore anemia.
Obesity and anemia
Obesity is characterized by chronic, low-grade, systemic infl ammation, elevated hepcidin, which, in turn has been associated with anemia of chronic disease. Ausk and Ioannou [91] hypothesized that obesity may be associated with the features of anemia of chronic disease, including low hemoglobin concentration, low serum iron and transferrin saturation, and elevated serum ferritin. Overweight and obesity were associated with changes in serum iron, transferrin saturation, and ferritin that would be expected to occur in the se ing of chronic, systemic infl ammation. Obesity-related infl ammation may increase hepcidin concentrations and reduce iron availability. Aeberli et al., [92] compared iron status, dietary iron intake and bioavailability, as well as circulating levels of hepcidin, leptin, and interleukin-6 (IL-6), in overweight versus normal weight children. They indicated that there is reduced iron availability for erythropoiesis in overweight children and that this is likely due to hepcidin-mediated reduced iron absorption and/or increased iron sequestration rather than low dietary iron supply.
Alcoholism
Alcohol has numerous adverse eff ects on the various types of blood cells and their functions. [93] Alcoholics frequently have defective RBCs that are destroyed prematurely. [93, 94] Alcohol itself may also be toxic to the bone marrow and may slow down the RBC production. [93, 94] In addition, poor nutrition and defi ciencies of vitamins and minerals are associated with alcoholism. [95] The combination of these factors may lead to anemia in alcoholics.
Sickle cell anemia
Sickle cell anemia is one of the most common inherited diseases. [96] It is a blood-related disorder that aff ects the hemoglobin molecule and causes the entire blood cell to change shape under stressed conditions. [97] In this condition, the hemoglobin problem is qualitative or functional. Abnormal hemoglobin molecules may cause problems in the integrity of the RBC structure and they may become crescent-shaped (sickle cells).
[97] There are diff erent types of sickle cell anemia with diff erent severity levels. It is particularly common in African, Middle Eastern, and Mediterranean ancestry.
[97] Thalassemia This is another group of hemoglobin-related causes of anemia, which involves the absence of or errors in genes responsible for production of hemoglobin.
[97] A hemoglobin molecule has subunits commonly referred to as alpha and beta globin chains. A lack of a particular subunit determines the type of alpha or beta thalassemia. [97, 98] There are many types of thalassemia, which vary in severity from mild (thalassemia minor) to severe (thalassemia major). [98] These are also hereditary, but they cause quantitative hemoglobin abnormalities, meaning an insufficient amount of the correct hemoglobin type molecules is made. The alpha and beta thalassemias are the most common-inherited single-gene disorders in the world with the highest prevalence in areas where malaria was or still is endemic. [97] Aplastic anemia Aplastic anemia is a disease in which the bone marrow is destructed and the production of blood cells is diminished. [99] This causes a deficiency of all three types of blood cells (pancytopenia) including RBCs (anemia), white blood cells (leukopenia), and platelets (thrombocytopenia). [100, 101] Many common medications can occasionally cause this type of anemia as a side eff ect in some individuals. [99] Hemolytic anemia Hemolytic anemia is a type of anemia in which the RBCs rupture, known as hemolysis, and are destroyed faster than the bone marrow can replace them. [102] Hemolytic anemia could happen due to a variety of reasons and is often categorized as acquired or hereditary. Common acquired causes of hemolytic anemia are autoimmunity, microangiopathy, and infection. Disorders of RBC enzymes, membranes, and hemoglobin cause hereditary hemolytic anemia. [102] 
PREVENTION OF IRON DEFICIENCY (INTERVENTION STRATEGIES)
The four principle strategies for correcting micronutrient effi ciencies in populations can be used for correcting iron defi ciency, either alone or in combination. These are education combined with dietary modifi cation, to improve iron intake and bioavailability; iron supplementation (provision of iron, usually in higher doses, without food), iron fortifi cation of foods and the new approach of biofortifi cation. However, there are some diffi culties in the application of some of these strategies when considering iron.
Food diversifi cation
Dietary modifi cations for reducing Indian Dental Association involve increased intake of iron rich foods, especially fl esh foods, increased consumption of fruits and vegetables rich in ascorbic acid to enhance nonheme iron absorption, and reduced intake of tea and coff ee, which inhibit nonheme iron absorption. [103, 58] Another strategy is to reduce antinutrient contents in order to make the iron supplied from their food sources more available. Iron bioavailability may be increased by techniques such as germination and fermentation, which promote enzymatic hydrolysis of phytic acid in whole grain cereals and legumes by enhancing the activity of endogenous or exogenous phytase enzymes. [104] Even the use of nonenzymatic methods, such as thermal processing, soaking, and milling, for reducing phytic acid content in plant-based staples has been successful in improving the bioavailability of iron (and zinc). [105, 106] 
Supplementation
For oral iron supplementation, ferrous iron salts (ferrous sulfate and ferrous gluconate) are preferred because of their low cost and high bioavailability. [72] Although iron absorption is higher when iron supplements are given on an empty stomach, nausea, and epigastric pain might develop due to the higher iron doses administered (usually 60 mg Fe/day). If such side-eff ects arise, lower doses between meals should be a empted or iron should be provided with meals, although food reduces absorption of medicinal iron by about two-thirds. [107] Iron supplementation during pregnancy is advisable in developing countries, where women o en enter pregnancy with low iron stores. [108] Although the benefits of iron supplementation have generally been considered to outweigh the putative risks, there is some evidence to suggest that supplementation at levels recommended for otherwise healthy children carries the risk of increased severity of infectious disease in the presence of malaria. [109, 110] Fortifi cation Fortification of foods with iron is more difficult than fortifi cation with nutrients, such as zinc in fl our, iodine in salt, and vitamin A in cooking oil. [72] The most bioavailable iron compounds are soluble in water or diluted acid but o en react with other food components to cause off -fl avors, color changes or fat oxidation. [103] Thus, less soluble forms of iron, although less well absorbed, are o en chosen for fortifi cation to avoid unwanted sensory changes. [72] Fortifi cation is usually made with much lower iron doses than supplementation. It is closer to the physiological environment and might be the safest intervention in malarious areas. [111] There is no concern over the safety of iron supplementation or iron fortifi cation in nonmalarial endemic areas. [112] Iron compounds recommended for food fortification by the [7] include ferrous sulfate, ferrous fumarate, ferric pyrophosphate, and electrolytic iron powder. Wheat fl our is the most common iron fortifi ed food and it is usually fortifi ed with elemental iron powders which are not recommended by WHO. [7, 113] Hurrell and Egli [23] reported that of the 78 national wheat flour programs only eight would be expected to improve iron status. These programs used recommended iron compounds at the recommended levels. The other countries used non recommended compounds or lower levels of iron relative to fl our intake. Commercial infant foods, such as formulas and cereals, are also commonly fortifi ed with iron.
Biofortifi cation
Iron contents vary from 25 to 56 mg/kg in the diff erent varieties of wheat and 7-23 mg/kg in rice grains. However, most of this iron is removed during the milling process. Iron absorption from cereals and legumes, many of which have high native iron content, is generally low because of their high contents of phytate and sometimes polyphenols. [48] Biofortifi cation strategies include plant breeding and genetic engineering. Iron levels in common beans and millet have been successfully increased by plant breeding but other staple is more diffi cult or not possible (rice) due to insuffi cient natural genetic variation. Lucca et al., [114] increased the iron content in rice endosperm to improve its absorption in the human intestine by means of genetic engineering. They introduced a ferritin gene from Phaseolus vulgaris into rice grains, increasing their iron content up to twofold. To increase iron bioavailability, they introduced a thermotolerant phytase from Aspergillus fumigatus into the rice endosperm. They indicated that this rice, with higher iron content and rich in phytase has a great potential to substantially improve iron nutrition in those populations where iron defi ciency is so widely spread. [114] Unfortunately the phytase did not resist cooking. The importance of various minerals as zinc [115] and iron needs more a ention at individual and public health levels.
